HK1162527A1 - Process for the production of bivalirudin - Google Patents
Process for the production of bivalirudinInfo
- Publication number
- HK1162527A1 HK1162527A1 HK12102674.5A HK12102674A HK1162527A1 HK 1162527 A1 HK1162527 A1 HK 1162527A1 HK 12102674 A HK12102674 A HK 12102674A HK 1162527 A1 HK1162527 A1 HK 1162527A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bivalirudin
- production
- Prior art date
Links
- OIRCOABEOLEUMC-GEJPAHFPSA-N bivalirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 OIRCOABEOLEUMC-GEJPAHFPSA-N 0.000 title 1
- 229960001500 bivalirudin Drugs 0.000 title 1
- 108010055460 bivalirudin Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08022479 | 2008-12-29 | ||
US26047109P | 2009-11-12 | 2009-11-12 | |
PCT/EP2009/009080 WO2010075983A1 (en) | 2008-12-29 | 2009-12-17 | Process for the production of bivalirudin |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1162527A1 true HK1162527A1 (en) | 2012-08-31 |
Family
ID=42060981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12102674.5A HK1162527A1 (en) | 2008-12-29 | 2012-03-16 | Process for the production of bivalirudin |
Country Status (19)
Country | Link |
---|---|
US (2) | US8921517B2 (xx) |
EP (1) | EP2382232B1 (xx) |
JP (2) | JP5730781B2 (xx) |
KR (1) | KR101653950B1 (xx) |
CN (3) | CN102264757B (xx) |
AR (1) | AR074944A1 (xx) |
AU (1) | AU2009335350A1 (xx) |
CA (2) | CA2744627C (xx) |
CO (1) | CO6400148A2 (xx) |
DK (1) | DK2382232T3 (xx) |
EA (1) | EA201101015A1 (xx) |
ES (1) | ES2439502T3 (xx) |
HK (1) | HK1162527A1 (xx) |
IL (1) | IL213457A (xx) |
MX (1) | MX2011006950A (xx) |
SG (1) | SG171859A1 (xx) |
TW (3) | TWI599580B (xx) |
WO (1) | WO2010075983A1 (xx) |
ZA (1) | ZA201104195B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006045503A1 (en) | 2004-10-19 | 2006-05-04 | Lonza Ag | Method for solid phase peptide synthesis |
CA2736126C (en) * | 2008-09-03 | 2016-11-29 | Scinopharm Taiwan Ltd. | Process for making bivalirudin |
US7985733B1 (en) | 2010-01-06 | 2011-07-26 | The Medicines Company | Buffer-based method for preparing bivalirudin drug product |
CN102816208B (zh) * | 2011-06-10 | 2016-11-23 | 江苏豪森药业集团有限公司 | 一种比伐卢定的液相合成方法 |
CN102532274B (zh) * | 2012-02-13 | 2014-04-23 | 成都圣诺生物制药有限公司 | 一种比伐卢定的制备方法 |
CN102731624B (zh) * | 2012-06-14 | 2015-09-23 | 无锡市凯利药业有限公司 | 一种固相片段法合成比伐卢定的方法 |
CN102702325B (zh) * | 2012-06-19 | 2015-09-23 | 深圳翰宇药业股份有限公司 | 一种抗凝血多肽的制备方法 |
US9976133B2 (en) * | 2012-06-20 | 2018-05-22 | The Regents Of The University Of California | Synzymes |
WO2014032257A1 (zh) * | 2012-08-30 | 2014-03-06 | 深圳翰宇药业股份有限公司 | 一种比伐卢定的制备方法 |
CN103965293B (zh) * | 2013-02-05 | 2020-02-14 | 深圳信立泰药业股份有限公司 | 一种高纯度比伐卢定及其工业化制备方法 |
CN103242431B (zh) * | 2013-05-20 | 2015-05-13 | 齐鲁制药有限公司 | 一种比伐卢定的制备方法 |
CN110204611B (zh) * | 2019-06-26 | 2023-11-07 | 海南中和药业股份有限公司 | 一种固相片段法合成比伐卢定 |
CN115073587A (zh) * | 2022-07-08 | 2022-09-20 | 厦门胜泽泰医药科技有限公司 | 一种半连续液相合成比伐芦定的合成工艺 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990003391A1 (en) * | 1988-09-29 | 1990-04-05 | Biogen, Inc. | Hirudin peptides |
US5196404B1 (en) * | 1989-08-18 | 1996-09-10 | Biogen Inc | Inhibitors of thrombin |
GB9708918D0 (en) | 1997-05-01 | 1997-06-25 | Ppl Therapeutics Scotland Ltd | Methods |
CN1688606A (zh) * | 2002-08-12 | 2005-10-26 | 昆士兰医学研究所理事会 | 含有辅助t细胞和b细胞表位的新的免疫原性脂肽 |
AU2004285951A1 (en) * | 2003-10-30 | 2005-05-12 | The University Of Massachusetts | New coupling agents for peptide synthesis |
WO2006045503A1 (en) * | 2004-10-19 | 2006-05-04 | Lonza Ag | Method for solid phase peptide synthesis |
ZA200707006B (en) * | 2005-01-25 | 2008-11-26 | Cell Therapeutics Inc | Conjugates of biologically active proteins having a modified in vivo half-life |
MX2007008982A (es) | 2005-01-25 | 2007-12-06 | Cell Therapeutics Inc | Conjugados de proteinas biologicamente activas que tienen una vida media modificada in vivo. |
MX2008003552A (es) * | 2005-09-14 | 2008-11-12 | Novetide Ltd | Proceso para la produccion de bivalirudina. |
US20070213505A1 (en) * | 2006-03-08 | 2007-09-13 | David Epstein | Solution Synthesis of Peptide Cell Growth Stimulators |
CN101033249B (zh) * | 2006-03-10 | 2011-05-11 | 周逸明 | 固相多肽合成比筏芦定的制备方法 |
CA2736126C (en) * | 2008-09-03 | 2016-11-29 | Scinopharm Taiwan Ltd. | Process for making bivalirudin |
-
2009
- 2009-12-17 DK DK09795927.4T patent/DK2382232T3/da active
- 2009-12-17 US US13/139,956 patent/US8921517B2/en active Active
- 2009-12-17 JP JP2011543985A patent/JP5730781B2/ja active Active
- 2009-12-17 AU AU2009335350A patent/AU2009335350A1/en not_active Abandoned
- 2009-12-17 CN CN200980152943.3A patent/CN102264757B/zh active Active
- 2009-12-17 KR KR1020117017887A patent/KR101653950B1/ko active IP Right Grant
- 2009-12-17 SG SG2011039179A patent/SG171859A1/en unknown
- 2009-12-17 CA CA2744627A patent/CA2744627C/en active Active
- 2009-12-17 EA EA201101015A patent/EA201101015A1/ru unknown
- 2009-12-17 CA CA2916716A patent/CA2916716C/en active Active
- 2009-12-17 ES ES09795927.4T patent/ES2439502T3/es active Active
- 2009-12-17 CN CN201410073797.8A patent/CN103864895A/zh active Pending
- 2009-12-17 MX MX2011006950A patent/MX2011006950A/es unknown
- 2009-12-17 WO PCT/EP2009/009080 patent/WO2010075983A1/en active Application Filing
- 2009-12-17 EP EP09795927.4A patent/EP2382232B1/en active Active
- 2009-12-17 CN CN201410073688.6A patent/CN103864894B/zh active Active
- 2009-12-21 TW TW105115041A patent/TWI599580B/zh not_active IP Right Cessation
- 2009-12-21 TW TW098143850A patent/TWI453216B/zh not_active IP Right Cessation
- 2009-12-21 TW TW103128940A patent/TWI538919B/zh not_active IP Right Cessation
- 2009-12-29 AR ARP090105164A patent/AR074944A1/es not_active Application Discontinuation
-
2011
- 2011-06-06 ZA ZA2011/04195A patent/ZA201104195B/en unknown
- 2011-06-09 IL IL213457A patent/IL213457A/en active IP Right Grant
- 2011-06-20 CO CO11076777A patent/CO6400148A2/es not_active Application Discontinuation
-
2012
- 2012-03-16 HK HK12102674.5A patent/HK1162527A1/xx not_active IP Right Cessation
-
2014
- 2014-11-25 US US14/552,807 patent/US20150080550A1/en not_active Abandoned
- 2014-11-27 JP JP2014240227A patent/JP5996618B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2913337T (pt) | Processo para a produção de sofosbuvir | |
HK1162527A1 (en) | Process for the production of bivalirudin | |
EP2271636A4 (en) | METHOD FOR PRODUCING DIANEHYDRO SUGAR | |
ZA201100807B (en) | Process for the continuous production of polyesters | |
ZA201201874B (en) | Process for the production of butadiene | |
EG25753A (en) | Process for the production of alcohols | |
PL2349962T3 (pl) | Sposób wytwarzania chlorofluorowodoroolefin | |
EP2325153A4 (en) | PROCESS FOR PREPARING ALUMINUM DIAMOND COMPOUND | |
ZA201102728B (en) | Process for the production of alcohol | |
GB2474310B (en) | Process for the production of sucrose-6-ester | |
EP2408725A4 (en) | PROCESS FOR THE PRODUCTION OF OLEFINES | |
HK1160097A1 (en) | Process for the production of ammonia | |
IL202153A0 (en) | Process for the production of pyrazoles | |
IL211555A0 (en) | Process for making bivalirudin | |
IL216942A0 (en) | Process for the manufacture of alkenones | |
EP2292579A4 (en) | PROCESS FOR THE PRODUCTION OF HALOGENATED FLUOROETHERS | |
GB2457820B (en) | Production process | |
IL243809A (en) | Process for the production of γ-ketosulfide compounds and γ-ketosulfide compounds obtained | |
EP2221294A4 (en) | PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN | |
PT2334594T (pt) | Processo para a produção de dióxido de cloro | |
HK1159639A1 (en) | Process for the production of organic dithiopyrophosphates | |
EP2251329A4 (en) | PROCESS FOR THE PRODUCTION OF 3-AMINO-2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE | |
GB0802224D0 (en) | Process for the production of vaccine components | |
GB0718398D0 (en) | Process for the production of alcohols | |
GB0803762D0 (en) | Production process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20231214 |